Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$727M |
| 3 |
Tesla
TSLA
|
+$402M |
| 4 |
NVIDIA
NVDA
|
+$372M |
| 5 |
AT&T
T
|
+$323M |
Top Sells
| 1 |
Cisco
CSCO
|
+$489M |
| 2 |
Broadcom
AVGO
|
+$428M |
| 3 |
Apple
AAPL
|
+$424M |
| 4 |
Netflix
NFLX
|
+$422M |
| 5 |
CELG
Celgene Corp
CELG
|
+$421M |
Sector Composition
| 1 | Technology | 20.52% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MOBL
2126
DELISTED
MobileIron, Inc.
MOBL
| $3.85M | ﹤0.01% |
791,860
+38,691
| +5% | +$188K |
|
2127
ANI Pharmaceuticals
ANIP
$2.14B
| $3.82M | ﹤0.01% |
61,863
-5,056
| -8% | -$312K |
|
|
MAXR
2128
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $3.81M | ﹤0.01% |
243,190
-41,410
| -15% | -$649K |
|
|
BPFH
2129
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $3.8M | ﹤0.01% |
316,110
-6,100
| -2% | -$73.4K |
|
2130
Ambac
AMBC
$414M
| $3.8M | ﹤0.01% |
176,222
-3,296
| -2% | -$71.1K |
|
2131
Vicor
VICR
$2.29B
| $3.79M | ﹤0.01% |
81,172
+12,159
| +18% | +$568K |
|
2132
RadNet
RDNT
$5.67B
| $3.78M | ﹤0.01% |
186,361
-45,794
| -20% | -$930K |
|
2133
Gannett
GCI
$632M
| $3.77M | ﹤0.01% |
591,097
+253,563
| +75% | +$1.62M |
|
2134
Cerus
CERS
$240M
| $3.77M | ﹤0.01% |
892,290
+231,849
| +35% | +$978K |
|
2135
Weibo
WB
$2.92B
| $3.77M | ﹤0.01% |
81,216
-12,312
| -13% | -$571K |
|
2136
Red Robin
RRGB
$122M
| $3.76M | ﹤0.01% |
113,934
+13,013
| +13% | +$430K |
|
2137
Marcus & Millichap
MMI
$1.29B
| $3.76M | ﹤0.01% |
100,921
-2,947
| -3% | -$110K |
|
2138
Standex International
SXI
$2.52B
| $3.75M | ﹤0.01% |
47,269
-1,001
| -2% | -$79.4K |
|
2139
LendingClub
LC
$1.92B
| $3.73M | ﹤0.01% |
295,648
-293,294
| -50% | -$3.7M |
|
2140
Hyster-Yale Materials Handling
HY
$655M
| $3.72M | ﹤0.01% |
63,130
-7,190
| -10% | -$424K |
|
2141
Standard BioTools
LAB
$508M
| $3.72M | ﹤0.01% |
1,069,498
-120,720
| -10% | -$420K |
|
2142
W&T Offshore
WTI
$258M
| $3.7M | ﹤0.01% |
664,489
-766
| -0.1% | -$4.26K |
|
2143
Artivion
AORT
$2B
| $3.69M | ﹤0.01% |
136,330
-41,609
| -23% | -$1.13M |
|
2144
BioCryst Pharmaceuticals
BCRX
$1.69B
| $3.69M | ﹤0.01% |
1,068,498
+245,616
| +30% | +$848K |
|
|
WPG
2145
DELISTED
Washington Prime Group Inc.
WPG
| $3.65M | ﹤0.01% |
111,537
-2,434
| -2% | -$79.7K |
|
2146
Shutterstock
SSTK
$750M
| $3.65M | ﹤0.01% |
85,060
+511
| +0.6% | +$21.9K |
|
2147
Evolent Health
EVH
$1.08B
| $3.65M | ﹤0.01% |
402,790
+4,147
| +1% | +$37.5K |
|
2148
Amneal Pharmaceuticals
AMRX
$3.17B
| $3.64M | ﹤0.01% |
754,424
+366,995
| +95% | +$1.77M |
|
|
DERM
2149
DELISTED
Dermira, Inc.
DERM
| $3.64M | ﹤0.01% |
239,800
+71,692
| +43% | +$1.09M |
|
2150
Koppers
KOP
$570M
| $3.63M | ﹤0.01% |
94,989
-89,311
| -48% | -$3.41M |
|